Orthostatic Hypotension in Diabetics in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial

Hypertension

Volumn 68, Issue 4, 2016, Pages 851-852

  Aronow, Wilbert S ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; NOTE; ORTHOSTATIC BLOOD PRESSURE; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BLOOD; CARDIOVASCULAR DISEASE; HYPERTENSION; RISK FACTOR;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; RISK FACTORS;

EID: 84981161381     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07605     Document Type: Note

References (10)

1. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037-2114. doi: 10.1016/j.jacc.2011.01.008.
2. Aronow WS, Ahn C. Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents. J Am Geriatr Soc. 1997;45:1051-1053.
3. Mader SL. Orthostatic hypotension. Med Clin North Am. 1989;73:1337-1349.
4. Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, Rosamond W, Sharrett AR, Szklo M. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Hypertens. 2000;13(6 pt 1):571-578.
5. Ricci F, Fedorowski A, Radico F, Romanello M, Tatasciore A, Di Nicola M, Zimarino M, De Caterina R. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36:1609-1617. doi: 10.1093/eurheartj/ehv093.
6. ACCORD Study Group. Effects of intensive blood pressure control in type 2 diabetes. N Engl J Med 2010; 362: 1575-1585.
7. Margolis KL, O'Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, Cutler JA, Evans GW, Gerstein HC, Grimm RH Jr, Lipkin EW, Narayan KM, Riddle MC Jr, Sood A, Goff DC Jr. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care. 2014;37:1721-1728. doi: 10.2337/dc13-2334.
8. Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. Hypertension. 2015;66:1123-1129. doi: 10.1161/HYPERTENSIONAHA.115.06236.
9. Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, Cutler JA, Grimm R, Pedley C, Peterson K, Pop-Busui R, Sperl-Hillen J, Cushman WC. Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance. Hypertension 2016; 68: 888-895. doi: 10.1161/HYPERTENSIONAHA.116.07474.
10. Wright JT, Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116.